Rare diseases
Investigational molecules
Locations
Back to Germany128 clinical trials in Karlsruhe, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Orforglipron in Overweight Adults at Risk of Developing Obesity‑Related Complications or Class 1 Obesity
GermanyA Phase 3 Study of Efitazanamivir Alfa for Preventing Influenza in Adults and Adolescents at High Risk of Complications
GermanyStudy of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyA study to evaluate the effect of survodutide on protein levels in the urine for patients with chronic kidney disease
GermanyStudy of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer
GermanyComparing two treatment regimens with drug combination for newly diagnosed low-risk medulloblastoma to evaluate cognitive function outcomes
GermanyStudy of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B
GermanyStudy on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features
GermanyStudy of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer
GermanyStudy on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination
GermanyStudy of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome
GermanyStudy on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on colorectal cancer, breast cancer, and various types of lymphomas. Studies evaluate novel combination therapies and targeted treatments for patients with different stages of disease.
Advanced trials exploring immunotherapy combinations and precision medicine approaches.
Groundbreaking studies in acute myeloid leukemia and chronic lymphocytic leukemia, testing innovative drug combinations and targeted therapies.
Focus on improving survival rates through personalized treatment strategies.
Research addressing chronic kidney disease, pulmonary diseases, and metabolic disorders. Studies evaluate new therapeutic options for managing long-term health conditions.
Emphasis on improving quality of life and disease outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
